COVID-19, mast cells, cytokine storm, psychological stress, and neuroinflammation

D Kempuraj, GP Selvakumar, ME Ahmed… - The …, 2020 - journals.sagepub.com
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) is a new pandemic infectious disease that originated in China …

[HTML][HTML] Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and glial cells: Insights and perspectives

G Vargas, LHM Geraldo, NG Salomão, MV Paes… - Brain, behavior, & …, 2020 - Elsevier
In December 2019, a pneumonia outbreak was reported in Wuhan, Hubei province, China.
Since then, the World Health Organization declared a public health emergency of …

SARS-CoV-2, an underestimated pathogen of the nervous system

S Jakhmola, O Indari, S Chatterjee, HC Jha - SN comprehensive clinical …, 2020 - Springer
Numerous clinical studies have reported neurological symptoms in COVID-19 patients since
the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), apart from …

Evidence of coronavirus (CoV) pathogenesis and emerging pathogen SARS-CoV-2 in the nervous system: a review on neurological impairments and manifestations

NK Jha, S Ojha, SK Jha, H Dureja, SK Singh… - Journal of molecular …, 2021 - Springer
Abstract The coronavirus disease 2019 (COVID-19) pandemic is an issue of global
significance that has taken the lives of many across the world. Severe acute respiratory …

Neurological toll of COVID-19

S Bhola, J Trisal, V Thakur, P Kaur, S Kulshrestha… - Neurological …, 2022 - Springer
The first case of coronavirus illness was discovered in Wuhan, China, in January 2020 and
quickly spread worldwide within the next couple of months. The condition was initially only …

Role of SARS-CoV-2 spike-protein-induced activation of microglia and mast cells in the pathogenesis of neuro-COVID

TC Theoharides, D Kempuraj - Cells, 2023 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus
disease 2019 (COVID-19). About 45% of COVID-19 patients experience several symptoms a …

Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms

Z Zhou, H Kang, S Li, X Zhao - Journal of neurology, 2020 - Springer
Abstract Coronavirus disease 2019 (COVID-19), a disease caused by the novel
betacoronavirus (SARS-CoV-2), has become a global pandemic threat. The potential …

Neurological manifestation of SARS-CoV-2 induced inflammation and possible therapeutic strategies against COVID-19

D Kumar, S Jahan, A Khan, AJ Siddiqui… - Molecular …, 2021 - Springer
There are regular reports of extrapulmonary infections and manifestations related to the
ongoing COVID-19 pandemic. Coronaviruses are potentially neurotropic, which renders …

Neuroinflammation and Its Impact on the Pathogenesis of COVID-19

MM Almutairi, F Sivandzade, TH Albekairi… - Frontiers in …, 2021 - frontiersin.org
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). The clinical manifestations of COVID-19 …

[HTML][HTML] Neurotropic viruses, astrocytes, and COVID-19

P Tavčar, M Potokar, M Kolenc, M Korva… - Frontiers in cellular …, 2021 - frontiersin.org
At the end of 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was
discovered in China, causing a new coronavirus disease, termed COVID-19 by the WHO on …